A highly effective component vaccine against nontyphoidal salmonella enterica infections

mBio

Volumn 6, Issue 5, 2015, Pages

  Ferreira, Rosana B R ^a,g   Valdez, Yanet ^a   Coombes, Brian K ^a   Sad, Subash ^b   Gouw, Joost W ^c   Brown, Eric M ^a   Li, Yuling ^a   Grassl, Guntram A ^a,e   Antunes, L Caetano M ^h   Gill, Navkiran ^a   Truong, Mimi ^a   Scholz, Roland ^a   Reynolds, Lisa A ^a   Krishnan, Laskshmi ^d   Zafer, Ahmed A ^d   Sal Man, Neta ⁱ   Lowden, Michael J ^a,f   Auweter, Sigrid D ^a   Foster, Leonard J ^c   Brett Finlaya, B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Civil and Environmental Engineering   (Canada)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h INSTITUTO OSWALDO CRUZ   (Brazil)

ⁱ BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SALMONELLOSIS VACCINE; BACTERIUM ANTIBODY; CULTURE MEDIUM; SECRETORY IMMUNOGLOBULIN; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BLOOD LEVEL; CONTROLLED STUDY; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FECES ANALYSIS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SUPERNATANT; SURVIVAL RATE; TYPHOID FEVER; ANIMAL; BACTEREMIA; BLOOD; CHEMISTRY; CULTURE MEDIUM; DISEASE MODEL; FECES; GASTROENTERITIS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; SALMONELLA INFECTIONS; SURVIVAL ANALYSIS;

ANIMALS; ANTIBODIES, BACTERIAL; BACTEREMIA; CULTURE MEDIA; DISEASE MODELS, ANIMAL; FECES; GASTROENTERITIS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INTESTINES; MICE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; SURVIVAL ANALYSIS; VACCINES, SUBUNIT;

EID: 84946595416     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01421-15     Document Type: Article

References (43)

1. Sánchez-Vargas FM, Abu-El-Haija MA, Gómez-Duarte OG. 2011. Salmonella infections: an update on epidemiology, management, and prevention. Travel Med Infect Dis 9:263-277. http://dx.doi.org/10.1016/j.tmaid.2011.11.001.
2. Centers for Disease Control and Prevention. 2010. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food—10 states, 2009. MMWR Morb Mortal Wkly Rep 59: 418-422.
3. Reddy EA, Shaw AV, Crump JA. 2010. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 10:417-432. http://dx.doi.org/10.1016/S1473-3099(10)70072-4.
4. Graham SM. 2010. Nontyphoidal salmonellosis in Africa. Curr Opin Infect Dis 23:409-414. http://dx.doi.org/10.1097/QCO.0b013e32833dd25d.
5. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O’Brien SJ, Jones TF, Fazil A, Hoekstra RM, International Collaboration on Enteric Disease “Burden of Illness” Studies. 2010. The global burden of nontyphoidal salmonella gastroenteritis. Clin Infect Dis 50:882-889. http://dx.doi.org/10.1086/650733.
6. Barton Behravesh C, Jones TF, Vugia DJ, Long C, Marcus R, Smith K, Thomas S, Zansky S, Fullerton KE, Henao OL, Scallan E, FoodNet Working Group. 2011. Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996-2005. J Infect Dis 204:263-267. http://dx.doi.org/10.1093/infdis/jir263.
7. Gordon MA. 2008. Salmonella infections in immunocompromised adults. J Infect 56:413-422. http://dx.doi.org/10.1016/j.jinf.2008.03.012.
8. Chimalizeni Y, Kawaza K, Molyneux E. 2010. The epidemiology and management of nontyphoidal salmonella infections. Adv Exp Med Biol 659:33-46. http://dx.doi.org/10.1007/978-1-4419-0981-7_3.
9. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL, Corkill JE, Hart CA, Gilks CF, Molyneux ME. 2002. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16:1633-1641. http://dx.doi.org/10.1097/00002030-200208160-00009.
10. Guzman CA, Borsutzky S, Griot-Wenk M, Metcalfe IC, Pearman J, Collioud A, Favre D, Dietrich G. 2006. Vaccines against typhoid fever. Vaccine 24:3804-3811. http://dx.doi.org/10.1016/j.vaccine.2005.07.111.
11. Sjölund-Karlsson M, Rickert R, Matar C, Pecic G, Howie RL, Joyce K, Medalla F, Barzilay EJ, Whichard JM. 2010. Salmonella isolates with decreased susceptibility to extended-spectrum cephalosporins in the United States. Foodborne Pathog Dis 7:1503-1509. http://dx.doi.org/10.1089/fpd.2010.0607.
12. Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, Barzilay EJ, Emerging Infections Program NARMS Working Group. 2011. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother 55:1148-1154. http://dx.doi.org/10.1128/AAC.01333-10.
13. Simon R, Tennant SM, Galen JE, Levine MM. 2011. Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge. Vaccine 29: 5094-5106. http://dx.doi.org/10.1016/j.vaccine.2011.05.022.
14. Jazani NH, Worobec E, Shahabi S, Nejad GB. 2005. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model. Can J Microbiol 51:319-324. http://dx.doi.org/10.1139/w05-008.
15. Eisenstein TK, Killar LM, Sultzer BM. 1984. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine-and serum-mediated protection. J Infect Dis 150:425-435. http://dx.doi.org/10.1093/infdis/150.3.425.
16. Gil-Cruz C, Bobat S, Marshall JL, Kingsley RA, Ross EA, Henderson IR, Leyton DL, Coughlan RE, Khan M, Jensen KT, Buckley CD, Dougan G, MacLennan IC, López-Macías C, Cunningham AF. 2009. The porin OmpD from nontyphoidal salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci U S A 106:9803-9808. http://dx.doi.org/10.1073/pnas.0812431106.
17. Muthukkumar S, Muthukkaruppan VR. 1993. Mechanism of protective immunity induced by porin-lipopolysaccharide against murine salmonellosis. Infect Immun 61:3017-3025.
18. McSorley SJ, Cookson BT, Jenkins MK. 2000. Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium. J Immunol 164:986-993. http://dx.doi.org/10.4049/jimmunol.164.2.986.
19. Potter AA, Klashinsky S, Li Y, Frey E, Townsend H, Rogan D, Erickson G, Hinkley S, Klopfenstein T, Moxley RA, Smith DR, Finlay BB. 2004. Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 22:362-369. http://dx.doi.org/10.1016/j.vaccine.2003.08.007.
20. Eriksson S, Lucchini S, Thompson A, Rhen M, Hinton JC. 2003. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol Microbiol 47:103-118. http://dx.doi.org/10.1046/j.1365-2958.2003.03313.x.
21. Prost LR, Daley ME, Le Sage V, Bader MW, Le Moual H, Klevit RE Miller SI. 2007. Activation of the bacterial sensor kinase PhoQ by acidic pH. Mol Cell 26:165-174. http://dx.doi.org/10.1016/j.molcel.2007.03.008.
22. Coombes BK, Brown NF, Valdez Y, Brumell JH, Finlay BB. 2004. Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL. J Biol Chem 279: 49804-49815. http://dx.doi.org/10.1074/jbc.M404299200.
23. Coburn B, Li Y, Owen D, Vallance BA, Finlay BB. 2005. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect Immun 73:3219-3227. http://dx.doi.org/10.1128/IAI.73.6.3219-3227.2005.
24. Barthel M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Rüssmann H, Hardt WD. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71:2839-2858. http://dx.doi.org/10.1128/IAI.71.5.2839-2858.2003.
25. Ferreira RB, Gill N, Willing BP, Antunes LC, Russell SL, Croxen MA, Finlay BB. 2011. The intestinal microbiota plays a role in salmonellainduced colitis independent of pathogen colonization. PLoS One 6:e20338. http://dx.doi.org/10.1371/journal.pone.0020338.
26. García Véscovi E, Soncini FC, Groisman EA. 1996. Mg2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell 84: 165-174. http://dx.doi.org/10.1016/S0092-8674(00)81003-X.
27. Charles RC, Harris JB, Chase MR, Lebrun LM, Sheikh A, LaRocque RC, Logvinenko T, Rollins SM, Tarique A, Hohmann EL, Rosenberg I, Krastins B, Sarracino DA, Qadri F, Calderwood SB, Ryan ET. 2009. Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium. PLoS One 4:e6994. http://dx.doi.org/10.1371/journal.pone.0006994.
28. Guo L, Lim KB, Gunn JS, Bainbridge B, Darveau RP, Hackett M, Miller SI. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-253. http://dx.doi.org/10.1126/science.276.5310.250.
29. Lee SJ, Liang L, Juarez S, Nanton MR, Gondwe EN, Msefula CL, Kayala MA, Necchi F, Heath JN, Hart P, Tsolis RM, Heyderman RS, MacLennan CA, Felgner PL, Davies DH, McSorley SJ. 2012. Identification of a common immune signature in murine and human systemic salmonellosis. Proc Natl Acad Sci U S A 109:4998-5003. http://dx.doi.org/10.1073/pnas.1111413109.
30. Charles RC, Sheikh A, Krastins B, Harris JB, Bhuiyan MS, LaRocque RC, Logvinenko T, Sarracino DA, Kudva IT, Eisenstein J, Podolsky MJ, Kalsy A, Brooks WA, Ludwig A, John M, Calderwood SB, Qadri F, Ryan ET. 2010. Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology. Clin Vaccine Immunol 17: 1188-1195. http://dx.doi.org/10.1128/CVI.00104-10.
31. Ortiz V, Isibasi A, García-Ortigoza E, Kumate J. 1989. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever. J Clin Microbiol 27:1640-1645.
32. Brown A, Hormaeche CE. 1989. The antibody response to salmonellae in mice and humans studied by immunoblots and ELISA. Microb Pathog 6:445-454.
33. Levine MM. 2011. “IDEAL”vaccines for resource poor settings. Vaccine 29 (Suppl 4): D116-D125. http://dx.doi.org/10.1016/j.vaccine.2011.11.090.
34. Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW. 2008. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 364:272-280. http://dx.doi.org/10.1016/j.ijpharm.2008.04.036.
35. Brumell JH, Rosenberger CM, Gotto GT, Marcus SL, Finlay BB. 2001. SifA permits survival and replication of Salmonella typhimurium in murine macrophages. Cell Microbiol 3:75-84. http://dx.doi.org/10.1046/j.1462-5822.2001.00087.x.
36. Pelicic V, Reyrat JM, Gicquel B. 1996. Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors. Mol Microbiol 20:919-925. http://dx.doi.org/10.1111/j.1365-2958.1996.tb02533.x.
37. Reference deleted.
38. Brumell JH, Kujat-Choy S, Brown NF, Vallance BA, Knodler LA, Finlay BB. 2003. SopD2 is a novel type III secreted effector of Salmonella typhimurium that targets late endocytic compartments upon delivery into host c e l l s. Traffic 4 :36-48. http://dx.doi.org/10.1034/j.1600-0854.2003.40106.x.
39. Rappsilber J, Ishihama Y, Mann M. 2003. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 75:663-670. http://dx.doi.org/10.1021/ac026117i.
40. Meiring HD, van der Heeft E, ten Hove GJ, de Jong APJM. 2002. Nanoscale LC-MS(n): technical design and applications to peptide and protein analysis. J Sep Sci 25:557-568. http://dx.doi.org/10.1002/1615-9314(20020601)25:9<557::AID-JSSC557_3.0.CO;2-F.
41. Mortensen P, Gouw JW, Olsen JV, Ong SE, Rigbolt KT, Bunkenborg J, Cox J, Foster LJ, Heck AJ, Blagoev B, Andersen JS, Mann M. 2010. MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. J Proteome Res 9:393-403. http://dx.doi.org/10.1021/pr900721e.
42. Beausoleil SA, Villén J, Gerber SA, Rush J, Gygi SP. 2006. A probabilitybased approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 24:1285-1292. http://dx.doi.org/10.1038/nbt1240.
43. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M. 2005. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4:1265-1272. http://dx.doi.org/10.1074/mcp.M500061-MCP200.